These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2338028)
1. Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet. Wang NS; Guo XB; Liu QD; Fu LC; Li GQ; Arnold K Chemotherapy; 1990; 36(3):177-84. PubMed ID: 2338028 [TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects. Schwartz DE; Weidekamm E; Mimica I; Heizmann P; Portmann R Chemotherapy; 1987; 33(1):1-8. PubMed ID: 3493885 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic properties and bioequivalence of two sulfadoxine/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers. Liu YM; Zhang KE; Liu Y; Zhang HC; Song YX; Pu HH; Lu C; Liu GY; Jia JY; Zheng QS; Zhu JM; Yu C Clin Ther; 2012 Nov; 34(11):2212-20. PubMed ID: 23084093 [TBL] [Abstract][Full Text] [Related]
4. Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers. Mansor SM; Navaratnam V; Mohamad M; Hussein S; Kumar A; Jamaludin A; Wernsdorfer WH Br J Clin Pharmacol; 1989 Mar; 27(3):381-6. PubMed ID: 2785812 [TBL] [Abstract][Full Text] [Related]
5. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. Weidekamm E; Schwartz DE; Dubach UC; Weber B Chemotherapy; 1987; 33(4):259-65. PubMed ID: 3608626 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria. Karbwang J; Back DJ; Bunnag D; Breckenridge AM Bull World Health Organ; 1990; 68(5):633-8. PubMed ID: 2289299 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of Fansimef components (mefloquine + sulfadoxine + pyrimethamine) in human plasma by two high-performance liquid chromatographic methods. Edstein MD; Lika ID; Chongsuphajaisiddhi T; Sabchareon A; Webster HK Ther Drug Monit; 1991 Mar; 13(2):146-51. PubMed ID: 2053122 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of pyrimethamine and mefloquine in human plasma by high-performance liquid chromatography with ultraviolet detection. Guenzi A; Cappelletti G; Scala A; Zanetti M J Chromatogr; 1989 Sep; 494():219-30. PubMed ID: 2584319 [TBL] [Abstract][Full Text] [Related]
9. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398 [TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects. Sarikabhuti B; Keschamrus N; Noeypatimanond S; Weidekamm E; Leimer R; Wernsdorfer W; Kölle EU Acta Trop; 1988 Sep; 45(3):217-24. PubMed ID: 2903623 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects. Karbwang J; Bunnag D; Breckenridge AM; Back DJ Eur J Clin Pharmacol; 1987; 32(2):173-7. PubMed ID: 3495440 [TBL] [Abstract][Full Text] [Related]
12. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM; Phiri DE; Sheth UK; Mukunyandela M Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440 [TBL] [Abstract][Full Text] [Related]
13. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Obua C; Ntale M; Lundblad MS; Mahindi M; Gustafsson LL; Ogwal-Okeng JW; Anokbonggo WW; Hellgren U Afr Health Sci; 2006 Jun; 6(2):86-92. PubMed ID: 16916298 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines. Bustos DG; Lazaro JE; Gay F; Pottier A; Laracas CJ; Traore B; Diquet B Trop Med Int Health; 2002 Jul; 7(7):584-91. PubMed ID: 12100441 [TBL] [Abstract][Full Text] [Related]
16. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778 [TBL] [Abstract][Full Text] [Related]
17. A phase I clinical trial of mefloquine in Brazilian male subjects. de Souza JM Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400 [TBL] [Abstract][Full Text] [Related]
18. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam. Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246 [TBL] [Abstract][Full Text] [Related]
19. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria. Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709 [TBL] [Abstract][Full Text] [Related]